These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21982686)

  • 1. [ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].
    de la Haba-Rodríguez JR; Ortiz-Morales MJ; Gómez-España MA; Aranda Aguilar E
    Med Clin (Barc); 2012 Apr; 138(10):456-7. PubMed ID: 21982686
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
    Boora GK; Kulkarni AA; Kanwar R; Beyerlein P; Qin R; Banck MS; Ruddy KJ; Pleticha J; Lynch CA; Behrens RJ; Züchner S; Loprinzi CL; Beutler AS
    J Neurol Sci; 2015 Oct; 357(1-2):35-40. PubMed ID: 26143528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xaliproden lessens oxaliplatin-mediated neuropathy.
    Susman E
    Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598880
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropathic pain associated with non-surgical treatment of breast cancer.
    Jung BF; Herrmann D; Griggs J; Oaklander AL; Dworkin RH
    Pain; 2005 Nov; 118(1-2):10-4. PubMed ID: 16213086
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
    Chan A; Chiang J; Lew KY; Chay WY
    J Clin Oncol; 2011 Jun; 29(16):e489; author reply e490-1. PubMed ID: 21482983
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
    Mitsuma A; Ando Y
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
    Atkins CD
    J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135996
    [No Abstract]   [Full Text] [Related]  

  • 9. [Single nucleotide polymorphism analysis in the GSTP1 and ABCC2 genes about neuropathy by the Oxaliplatin].
    Mori Y; Katsumata K; Tsuchida A; Aoki T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2377-81. PubMed ID: 19098406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral neuropathy induced by anticancer drugs].
    Oishi R; Egashira N
    Fukuoka Igaku Zasshi; 2013 May; 104(5):71-80. PubMed ID: 23885391
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral sensory neuropathy--fighting cold with cold.
    Castro M
    Lancet Oncol; 2008 May; 9(5):415-6. PubMed ID: 18452855
    [No Abstract]   [Full Text] [Related]  

  • 12. Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.
    Sundar R; Jeyasekharan AD; Pang B; Soong RC; Kumarakulasinghe NB; Ow SG; Ho J; Lim JS; Tan DS; Wilder-Smith EP; Bandla A; Tan SS; Asuncion BR; Fazreen Z; Hoppe MM; Putti TC; Poh LM; Goh BC; Lee SC
    PLoS One; 2016; 11(10):e0164319. PubMed ID: 27716814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?
    Dittrich C; Zifko U; Fazeny B; Fiegl M; Grisold W; Huber H
    Ann Oncol; 1994 May; 5(5):473-4. PubMed ID: 7915538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 15. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome.
    Hogan-Dann CM; Fellmeth WG; McGuire SA; Kiley VA
    JAMA; 1984 Nov 23-30; 252(20):2862-3. PubMed ID: 6092732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked Charcot-Marie-Tooth disease with novel c.47A>T GJB1 gene mutation.
    Vrancken AF; Spliet WG; van Ruissen F
    J Peripher Nerv Syst; 2010 Jun; 15(2):156-7. PubMed ID: 20626781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer].
    Santos-García D; Prieto JM; Lema M
    Rev Neurol; 2009 Jan 16-31; 48(2):71-4. PubMed ID: 19173204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
    Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platinum drugs].
    Kusaba H; Baba E
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():143-5. PubMed ID: 25831739
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between Met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy.
    Azoulay D; Leibovici A; Sharoni R; Shaoul E; Gross B; Braester A; Goldberg H
    Breast Cancer Res Treat; 2015 Oct; 153(3):703-4. PubMed ID: 26272744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.